Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO My JCO Subscriptions Customer Service Site Map

Journal of Clinical Oncology, Vol 25, No 18 (June 20), 2007: pp. 2516-2521
© 2007 American Society of Clinical Oncology.
DOI: 10.1200/JCO.2006.09.5539

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bickell, N. A.
Right arrow Articles by Leventhal, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bickell, N. A.
Right arrow Articles by Leventhal, H.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Lost Opportunities: Physicians' Reasons and Disparities in Breast Cancer Treatment

Nina A. Bickell, Felice LePar, Jason J. Wang, Howard Leventhal

From the Department of Health Policy and Department of Medicine, Mount Sinai School of Medicine, New York, NY; and the Center for the Study of Health Beliefs and Behaviors, Rutgers State University of New Jersey, New Brunswick, NJ

Address reprint requests to Nina A. Bickell, MD, MPH, Mount Sinai School of Medicine, Department of Health Policy, 1 Gustave L. Levy Place, Box 1077, New York, NY 10029; e-mail: Nina.Bickell{at}mssm.edu

Purpose Women with breast cancer do not consistently receive adjuvant treatments that have been shown to increase survival. Acquiring an understanding of the reasons for these lost opportunities may inform strategies for quality improvement.

Methods Interviews were conducted with surgeons treating 119 women who did not receive guideline-recommended adjuvant therapy to ascertain reasons underlying treatment omission. Primary reason for underuse was categorized as not recommended, recommended but declined, or system failure (treatment recommended, not refused but did not ensue). Logistic regression identified patient characteristics, and surgeons' practice and referral patterns associated with underuse.

Results Surgeons did not recommend adjuvant treatment for 41 (34%) of 119 women, most often because perceived risks exceeded benefits (37 of 119; 31%); unawareness of treatment benefits was rare (four of 119; 3%). Among the 78 (66%) of 119 for whom surgeons recommended treatment, 37 (31%) declined therapy; 41 (34%) system failures occurred. System failures occurred more commonly among minority than white women (73% v 54%; P < .01), and more commonly in women who were receiving Medicaid or were uninsured than those with Medicare or commercial insurance (54% v 19%; P < .01). Women treated by a surgeon who works closely with oncologists were less likely to experience a system failure (84% v 68%; P < .05).

Conclusion One third of underuse episodes were attributable to surgeons' perceptions that treatment was not indicated, one third because women did not accept recommendations, and one third were the result of system failures. Reasons for underuse of adjuvant breast cancer treatments appear multifactorial and this heterogeneity suggests the need for simultaneous development of different strategies to improve care.

Supported by the Agency for Healthcare Research and Quality Grant No. P-01HS10859-02, the Commonwealth Fund Grant No. 20010102, and the National Center on Minority Health and Health Disparities Grant No. P60 MD00270.

The funders did not have a role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript.

Presented at the Annual Meeting of the Society of General Internal Medicine, New Orleans, LA, May 2005.

Authors' disclosures of potential conflicts of interest and author contributions are found at the end of this article.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
JCOHome page
N. A. Bickell, J. Weidmann, K. Fei, J. J. Lin, and H. Leventhal
Underuse of Breast Cancer Adjuvant Treatment: Patient Knowledge, Beliefs, and Medical Mistrust
J. Clin. Oncol., November 1, 2009; 27(31): 5160 - 5167.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
N. A. Bickell, K. Shastri, K. Fei, S. Oluwole, H. Godfrey, K. Hiotis, A. Srinivasan, and A. A. Guth
A Tracking and Feedback Registry to Reduce Racial Disparities in Breast Cancer Care
J Natl Cancer Inst, December 3, 2008; 100(23): 1717 - 1723.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
R. A. Freedman and E. P. Winer
Reducing Disparities in Breast Cancer Care--A Daunting but Essential Responsibility
J Natl Cancer Inst, December 3, 2008; 100(23): 1661 - 1663.
[Full Text] [PDF]



About
JCO
 Editorial
Roster
 Advertising
Information
 Librarians &
Institutions
 Rights &
Permissions
 PDA Services

Copyright © 2007 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online